The cash flow of ADMA BIOLOGICS, INC. over the past 10 years
Chart ADMA BIOLOGICS, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, ADMA BIOLOGICS, INC.'s operating cash flow was $50.4M and its capital expenditures $22.57M, leaving free cash flow of $27.82M. Free cash flow was above zero in 3 of the 10 years shown. It ranged from -$125.88M in fiscal 2021 to $110.45M in fiscal 2024. Capital expenditures were highest in fiscal 2025, at $22.57M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $50.4M | $22.57M | $27.82M |
| 2024ended Dec 31, 2024 | $118.67M | $8.23M | $110.45M |
| 2023ended Dec 31, 2023 | $8.8M | $4.77M | $4.03M |
| 2022ended Dec 31, 2022 | -$59.51M | $13.91M | -$73.42M |
| 2021ended Dec 31, 2021 | -$112.37M | $13.51M | -$125.88M |
| 2020ended Dec 31, 2020 | -$102M | $12.73M | -$114.73M |
| 2019ended Dec 31, 2019 | -$76.19M | $3.81M | -$80.01M |
| 2018ended Dec 31, 2018 | -$62.68M | $2.1M | -$64.77M |
| 2017ended Dec 31, 2017 | -$37.27M | $2.68M | -$39.95M |
| 2016ended Dec 31, 2016 | -$18.27M | $73.41K | -$18.34M |
Fiscal years as ADMA BIOLOGICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ADMA BIOLOGICS, INC.
- The revenue of ADMA BIOLOGICS, INC.
- The profitability of ADMA BIOLOGICS, INC.
- The debt of ADMA BIOLOGICS, INC.
- All of ADMA BIOLOGICS, INC.'s financials, charted
Companies of a similar size
Not investment advice. This page shows what ADMA BIOLOGICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.